ENDV   $0.0111  -13.28% Market Closed

Endonovo Therapeutics Inc
Total Cash
totalCashPerShare
EBITDA -1.97M
Total Debt 7.06M
quickRatio
currentRatio 0.001
Total Revenue 255.72K
debtToEquity
Revenue/Share 0.001
ROA -1.44267
ROE
grossProfits
freeCashflow 2.15M
operatingCashflow -629.90K
earningsGrowth
revenueGrowth -0.861
grossMargins 0.96211
ebitdaMargins 0.0
operatingMargins -311.05066
profitMargins 0.0
enterpriseValue
forwardPE
floatShares 243.40M
sharesOutstanding 318.75M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.25%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.072
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -4.40M
trailingEps -0.07%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 1
lastUpdated April 1, 2024, 2:34 p.m.